Alpha Teknova Inc
General ticker "TKNO" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $347.5M
Alpha Teknova Inc follows the US Stock Market performance with the rate: 41.3%.
Estimated limits based on current volatility of 4.9%: low 7.32$, high 8.07$
Factors to consider:
- US accounted for 96.8% of revenue in the fiscal year ended 2022-12-31
- Current price 40.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.23$, 5.48$]
- 2024-12-30 to 2025-12-30 estimated range: [2.34$, 5.64$]
Financial Metrics affecting the TKNO estimates:
- Negative: Non-GAAP EPS, $ of -1.12 <= 0.10
- Negative: Operating profit margin, % of -49.22 <= 1.03
- Negative: Operating cash flow per share per price, % of -16.41 <= 2.35
- Negative: negative Net income
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
Short-term TKNO quotes
Long-term TKNO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $36.89MM | $41.42MM | $36.68MM |
| Operating Expenses | $48.90MM | $91.08MM | $72.25MM |
| Operating Income | $-12.01MM | $-49.66MM | $-35.56MM |
| Non-Operating Income | $-0.63MM | $0.27MM | $-1.51MM |
| Interest Expense | $0.59MM | $0.21MM | $0.83MM |
| R&D Expense | $4.31MM | $7.74MM | $5.57MM |
| Income(Loss) | $-12.64MM | $-49.39MM | $-37.08MM |
| Taxes | $-2.83MM | $-1.92MM | $-0.30MM |
| Profit(Loss) | $-9.80MM | $-47.47MM | $-36.78MM |
| Stockholders Equity | $143.20MM | $99.89MM | $90.04MM |
| Inventory | $5.39MM | $12.25MM | $11.59MM |
| Assets | $166.51MM | $152.26MM | $128.59MM |
| Operating Cash Flow | $-9.07MM | $-27.40MM | $-18.81MM |
| Capital expenditure | $19.88MM | $28.15MM | $7.93MM |
| Investing Cash Flow | $-17.52MM | $-28.15MM | $-7.74MM |
| Financing Cash Flow | $110.79MM | $10.27MM | $12.80MM |
| Earnings Per Share* | $-0.35 | $-1.69 | $-1.16 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.